Krulder J W, Strebus A F, Meinders A E, Briët E
Department of General Internal Medicine, University Hospital, Leiden, The Netherlands.
Haemostasis. 1996 Mar-Apr;26(2):85-9. doi: 10.1159/000217192.
The aim of the study was to determine the effect of the antithrombin concentration on the anticoagulant response to heparin in vitro. Pooled plasma was depleted of antithrombin using heparin Sepharose. Unfractionated heparin (final concentration between 0 and 1 U/ml) was added to plasma with different antithrombin concentrations, and the activated partial thromboplastin time (APTT) was determined. Plasma with an antithrombin concentration over 0.27 U/ml shows a similar response to heparin as normal plasma; at lower levels the response is diminished. Even in plasma fully depleted of antithrombin, the APTT can be prolonged to a therapeutic level, although the amount of heparin needed is twice as high. At antithrombin concentrations over 0.27 U/ml, heparin is the major determinant of the anticoagulant effect.
本研究的目的是确定抗凝血酶浓度对体外肝素抗凝反应的影响。使用肝素琼脂糖去除混合血浆中的抗凝血酶。将不同抗凝血酶浓度的血浆加入终浓度为0至1 U/ml的普通肝素,并测定活化部分凝血活酶时间(APTT)。抗凝血酶浓度超过0.27 U/ml的血浆对肝素的反应与正常血浆相似;浓度较低时反应减弱。即使是抗凝血酶完全耗尽的血浆,APTT也可延长至治疗水平,尽管所需肝素量是正常情况的两倍。抗凝血酶浓度超过0.27 U/ml时,肝素是抗凝作用的主要决定因素。